SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-001206
Filing Date
2024-04-03
Accepted
2024-04-03 07:00:19
Documents
9
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 6-K zk2431235.htm 6-K 19131
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 72964
3 EXHIBIT 1.2 exhibit_1-2.htm EX-1.2 86047
4 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9689
5 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 15928
6 image00001.jpg GRAPHIC 5995
7 image00003.jpg GRAPHIC 21798
8 image00004.jpg GRAPHIC 24932
9 image00005.jpg GRAPHIC 8237
  Complete submission text file 0001178913-24-001206.txt   289197
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 24816822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)